A review of 16 studies linked presurgical melatonin and zolpidem to less postoperative pain, with over 30% less opioid use in some patients.

AI is speeding up managed care pharmacy work, but two pharmacists say human review remains key when tools affect patients' access to medications.

Prime Therapeutics' Pat Gleason, Pharm.D., outlined T1D screening gaps for plans and his priorities as incoming AMCP president.

Healthcare affordability has emerged as an issue in the Nov. 3 elections that will determine control of the Senate and the House.

Research presented at AMCP Nexus this week explores barriers to prescriptions for atopic dermatitis.

Adults newly diagnosed with narcolepsy type 1 rack up healthcare costs 5.5 times higher than people without the condition, a Takeda-funded analysis finds, even with treatments available.

Federal HIV guidelines add Bixlenvo as a switch option, back statins for adults 40 to 75 and urge clinicians to challenge payer barriers to antiretroviral therapy (ART).

Sempre Health CEO Anurati Mathur says affordability dollars should reach patients on every fill, and reversed claims show plans when they don’t.